Abstract: A compound represented by Formula (1): The compound can be used as insecticides.

Abstract: A method of producing a polyamine compound, the method including: a first step of generating a polyurea compound by reacting a thiourethane resin and an amine compound A with each other; and a second step of generating a polyamine compound by reacting the polyurea compound and an amine compound B with each other.

Abstract: A xylylene diisocyanate, a compound represented by the following chemical formula (1), and a compound represented by the following chemical formula (2) are contained in a xylylene diisocyanate composition.

Abstract: Provided is a curable composition that has a sufficient pot life and does not cause a significant delay in curing time even after long-term storage at room temperature or higher. A separately packed curable composition includes: (A) a first pack containing: (a1) a polymerizable monomer having no acidic group, (b) a polymerizable monomer having an acidic group, and (c) a transition metal compound; and (B) a second pack containing: (a2) a polymerizable monomer having no acidic group, (d) an aromatic amine compound, and (e) at least one compound selected from sulfinic acid and a salt thereof.

Abstract: Provided is a compound represented by General Formula (1) in General Formula (1), Ar1 and Ar2 independently represent a group selected from the following Formulae,

Abstract: Provided are an insolation correction method, an insolation correction device, a recording medium, a model, a model generating method, and a model providing method in which insolation data having a small deviation from an actually measured value can be provided. An insolation correction method includes: acquiring insolation data; acquiring weather data; and correcting the acquired insolation data, on the basis of the acquired weather data.

Abstract: A composition includes: a compound (A), having an Si—O bond and a cationic functional group that includes at least one selected from the group consisting of a primary nitrogen atom and a secondary nitrogen atom; a compound (B), having at least three —C(?O)OX groups, wherein X is a hydrogen atom or an alkyl group with a carbon number of from 1 to 6, and from one to six of the —C(?O)OX groups is a —C(?O)OH group; and a compound (C), having a cyclic structure and at least one primary nitrogen atom that is directly bonded to the cyclic structure, the composition having a percentage of the primary and the secondary nitrogen atoms in the compound (A), with respect to a total amount of the primary and the secondary nitrogen atoms in the compound (A) and the primary nitrogen atom in the compound (C), of from 3 mol % to 95 mol %.

Abstract: The present invention addresses the problem of providing a device for training in ophthalmic surgery that can be used for training in glaucoma surgery. The problem can be solved by a device for training in ophthalmic surgery including: a simulated-eyeball pedestal having a recess into which a simulated eyeball can be directly or indirectly inserted; a simulated eyeball insertable into the simulated-eyeball pedestal, or a member for retaining a simulated eyeball that retains a simulated eyeball, the member for retaining the simulated eyeball being insertable into the simulated-eyeball pedestal; and a mechanism for generating a restoring force that generates a force for restoring a position of the simulated eyeball or the simulated-eyeball retaining member toward a normal state with respect to the simulated-eyeball pedestal; the simulated eyeball or the member for retaining the simulated eyeball rotating along the recess of the simulated-eyeball pedestal.

Abstract: A method of producing lithium difluorophosphate, the method including: a step of obtaining a first raw material mixture by mixing lithium hexafluorophosphate, at least one selected from the group consisting of an oxide of phosphorus (A) and a lithium salt of a phosphoric acid (B), and a hydrocarbon solvent having from 6 to 12 carbon atoms; a step of obtaining a second raw material mixture by removing at least a part of the hydrocarbon solvent contained in the obtained first raw material mixture; and a step of producing a crude product containing lithium difluorophosphate by reacting the second raw material mixture.

Abstract: A polynucleotide of any one of the following: (1a) a polynucleotide including a base sequence of not less than 15 consecutive bases in base sequence A of any one of SEQ ID NO:1 to SEQ ID NO:9; (1b) a polynucleotide that hybridizes with a polynucleotide including the base sequence complementary to base sequence A, under stringent conditions: (1c) a polynucleotide including a base sequence having a sequence identity of not less than 80% to base sequence A; or (1d) a polynucleotide including a base sequence that is the same as base sequence A except that one or several bases are deleted, substituted, inserted, and/or added.

Abstract: A headache cause determination system includes a computer. The computer includes a CPU, a storage unit, and a determination unit executed by the CPU. The storage unit is configured to store data that enables a determination as to whether or not there is a possibility that a cause of the migraine symptom of the user is a light-based cause, based on question information regarding the migraine symptom of the user and response information regarding the user's response to the question information. The determination unit is configured to determine whether or not there is a possibility that a cause of the migraine symptom of the user is a light-based cause, based on the response information regarding the user's response to the question information and based on the data stored in the storage unit, and to output a result of the determination.

Abstract: Described is a cyclic olefin-based copolymer has a constitutional unit (A) derived from an ?-olefin having 2 to 20 carbon atoms, a constitutional unit (B) derived from a cyclic olefin without an aromatic ring, and a constitutional unit (C) derived from a cyclic olefin having an aromatic ring. Also described is a medical container containing a cyclic olefin-based copolymer having a constitutional unit (A) derived from an ?-olefin having 2 to 20 carbon atoms, a constitutional unit (B) derived from a cyclic olefin without an aromatic ring, and a constitutional unit (C) derived from a cyclic olefin having an aromatic ring.

Abstract: The present invention provides: a piezoelectric substrate which includes a first piezoelectric body having an elongated shape and helically wound in one direction, and which does not include a core material, in which the first piezoelectric body includes a helical chiral polymer (A) having an optical activity; in which the length direction of the first piezoelectric body is substantially parallel to the main direction of orientation of the helical chiral polymer (A) included in the first piezoelectric body; and in which the first piezoelectric body has a degree of orientation F, as measured by X-ray diffraction according to the following Equation (a), within the range of 0.5 or more but less than 1.0: degree of orientation F=(180°??)/180°??(a) (in which ? represents the half-value width of the peak derived from the orientation).

Abstract: An electretized film of the present invention includes a cyclic olefin polymer, in which the electretized film is a non-porous film, and a piezoelectric constant d33 in a thickness direction, which is measured by applying a pressing force to the electretized film in the thickness direction, under conditions of a load of 0.5 N, a dynamic load of ±0.25 N, a frequency of 110 Hz, a temperature of 23° C., and a humidity of 50%, is equal to or more than 100 pC/N.

Abstract: Provided is a primer pair of primers for methicillin-resistant gene detection for the purpose of achieving highly sensitive methicillin-resistant gene detection. Said primer pair comprises a combination of SEQ ID NO: 3 and SEQ ID NO: 7, a combination of SEQ ID NO: 2 and SEQ ID NO: 9, a combination of SEQ ID NO: 1 and SEQ ID NO: 8, a combination of SEQ ID NO: 1 and SEQ ID NO: 9, a combination of SEQ ID NO: 4 and SEQ ID NO: 11, a combination of SEQ ID NO: 5 and SEQ ID NO: 12, a combination of SEQ ID NO: 6 and SEQ ID NO: 10, or a combination of SEQ ID NO: 6 and SEQ ID NO: 12.

Abstract: A pellicle including: a pellicle film including a carbon-based film having a carbon content rate of 40 mass % or more; a support frame that supports the pellicle film; and an adhesive layer containing an adhesive, the pellicle having the total amount of aqueous outgas of 5.0×10?4 Pa·L/sec or less in an atmosphere of 23° C. and 1×10?3 Pa or less.

Abstract: A photocurable composition, wherein: in a case in which a rectangular sheet-like test piece P1 is produced by photomodeling under conditions in which the photocurable composition is irradiated with visible light having a wavelength of 405 nm at an irradiation dose of 11 mJ/cm2 to form a cured layer P1 with a thickness of 50 ?m, the cured layer P1 is stacked in a thickness direction thereof to form the rectangular sheet-like modeling product P1 with a length of 40 mm, a width of 10 mm, and a thickness of 0.5 mm, and the modeling product P1 is irradiated with ultraviolet rays having a wavelength of 365 nm at an irradiation dose of 3 J/cm2 to produce the test piece P1, the storage modulus at 135° C. of the test piece P1 is 3.0×108 Pa or more.

Abstract: A polymerization initiator includes a transition metal compound, a nitrogen-containing compound, and a sulfonyl group-containing compound.

Abstract: An adenocarcinoma detection method based on a protein fragment of WFDC2 protein in a sample originating from a subject, the method comprising determining a presence of adenocarcinoma by comparing a first determination value and a threshold value set in advance, the first determination value being a value derived by dividing a first fragment quantity, which is a quantity of a protein fragment having an amino acid sequence of SEQ ID NO: 1 in the sample as determined by an ELISA method, by a reference quantity defined by a total quantity of WFDC2 protein or a creatinine concentration in the sample as determined by an ELISA method.

Abstract: A polymerizable composition for an optical material according to the present invention includes a photochromic composition (A), and a polymerizable composition (B) including a bi- or higher functional iso(thio)cyanate compound and a bi- or higher functional active hydrogen compound, in which the photochromic composition (A) is a composition including at least three types of photochromic compounds (i) to (iii), the photochromic compound (i) has a structure including a chromophore a and a monovalent or a divalent organic group including one or more types of a polysiloxane chain or a polyoxyalkylene chain, the photochromic compound (ii) has the chromophore a (which is not the photochromic compound (i)), and the photochromic compound (iii) has a chromophore b different from the chromophore a.